Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Julphar
Covington
McKesson
Teva
Chubb
QuintilesIMS
Queensland Health

Generated: May 24, 2018

DrugPatentWatch Database Preview

PRELUDIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Preludin patents expire, and what generic alternatives are available?

Preludin is a drug marketed by Boehringer Ingelheim and is included in two NDAs.

The generic ingredient in PRELUDIN is phenmetrazine hydrochloride. Additional details are available on the phenmetrazine hydrochloride profile page.
Summary for PRELUDIN
Drug patent expirations by year for PRELUDIN
Medical Subject Heading (MeSH) Categories for PRELUDIN
Synonyms for PRELUDIN
134-49-6 (Parent)
1707-14-8
2-Phenyl-3-methyltetrahydro-1,4-oxazine hydrochloride
3-methyl-2-phenyl-morpholine
3-Methyl-2-phenylmorpholine hydrochloride
3-Methyl-2-phenyltetrahydro-2H-1,4-oxazine hydrochloride
A 66 hydrochloride
AC1L3NJM
AC1Q3EVN
AK-63057
AKOS022181094
API0009051
C11H15NO.HCl
CAS-1707-14-8
CHEBI:8068
CHEMBL1200483
D05454
DEA No. 1631
DSSTox_CID_27799
DSSTox_GSID_47822
DSSTox_RID_82571
DTXSID0047822
EINECS 216-950-6
FT-0673699
LS-93174
Marsin
Marsine
Mefolin
Morpholine, 3-methyl-2-phenyl-, hydrochloride
NCGC00164535-01
NCGC00164535-02
Neo-zine
NSC 405728
NSC-405728
NSC405728
Phenmetraline HCl
Phenmetraline Hydrochloride
Phenmetrazine chloride
Phenmetrazine HCl
Phenmetrazine hydrochloride
Phenmetrazine hydrochloride (USP)
Phenmetrazine Hydrochloride [USAN]
PHENMETRAZINE METHYLCHLORIDE
Preludin (TN)
Probese-P hydrochloride
Psychamine A 66 hydrochloride
SCHEMBL121536
Tox21_112166
Tox21_112166_1
USAF GE-1
WLN: T6M DOTJ B1 CR &GH

US Patents and Regulatory Information for PRELUDIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim PRELUDIN phenmetrazine hydrochloride TABLET, EXTENDED RELEASE;ORAL 011752-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim PRELUDIN phenmetrazine hydrochloride TABLET, EXTENDED RELEASE;ORAL 011752-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Boehringer Ingelheim PRELUDIN phenmetrazine hydrochloride TABLET;ORAL 010460-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKinsey
Julphar
Medtronic
Cantor Fitzgerald
Citi
McKesson
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.